Jürgen Wolf Selected Research

Enzymes

11/2023	Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summary.
6/2011	Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on 4-anilinoquinazolines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jürgen Wolf Research Topics

Disease

53	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 01/2008
50	Neoplasms (Cancer) 01/2024 - 01/2002
40	Lung Neoplasms (Lung Cancer) 04/2024 - 01/2008
9	Disease Progression 03/2024 - 12/2011
8	Adenocarcinoma of Lung 01/2019 - 12/2010
6	Diarrhea 11/2023 - 01/2011
6	Neoplasm Metastasis (Metastasis) 01/2023 - 03/2010
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2024 - 02/2014
4	Exanthema (Rash) 10/2023 - 01/2011
3	Nausea 11/2023 - 03/2011
3	Melanoma (Melanoma, Malignant) 10/2023 - 08/2015
3	Hypertension (High Blood Pressure) 10/2022 - 03/2011
3	Myocardial Infarction 01/2012 - 03/2006
2	Fatigue 01/2023 - 03/2011
2	Adenocarcinoma 01/2023 - 10/2016
2	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2019
2	Multiple Myeloma 01/2018 - 11/2005
2	Sarcoma (Soft Tissue Sarcoma) 02/2017 - 06/2009
2	Small Cell Carcinoma 02/2016 - 02/2015
2	Colorectal Neoplasms (Colorectal Cancer) 08/2015 - 05/2007
2	Infarction (Infarctions) 01/2012 - 04/2010
2	Breast Neoplasms (Breast Cancer) 06/2011 - 01/2011
2	Ventricular Remodeling 09/2008 - 03/2006
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2005 - 07/2004
2	Hodgkin Disease (Hodgkin's Disease) 11/2005 - 01/2002
1	Dizziness (Lightheadedness) 01/2024
1	Dysgeusia (Parageusia) 01/2024
1	Paresthesia (Dysesthesia) 01/2024
1	Neuroblastoma 10/2023
1	Dermatitis 10/2023
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 10/2023
1	Febrile Neutropenia 01/2023
1	Neutropenia 01/2023
1	Cough 01/2023

Drug/Important Bio-Agent (IBA)

17	Tyrosine Kinase InhibitorsIBA 04/2024 - 05/2011
14	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019 - 01/2008
11	Biomarkers (Surrogate Marker)IBA 03/2024 - 05/2011
10	ErbB Receptors (EGF Receptor)IBA 04/2024 - 01/2008
10	Phosphotransferases (Kinase)IBA 10/2023 - 11/2005
7	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 09/2017 - 12/2010
6	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2002
6	CrizotinibIBA 01/2019 - 09/2014
5	LigandsIBA 12/2023 - 02/2014
5	selpercatinibIBA 11/2023 - 01/2020
5	Anaplastic Lymphoma KinaseIBA 01/2018 - 12/2010
5	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 01/2008
4	DNA (Deoxyribonucleic Acid)IBA 05/2024 - 09/2012
4	Immune Checkpoint InhibitorsIBA 12/2023 - 03/2015
4	sotorasibIBA 11/2023 - 01/2021
4	ThymidineIBA 01/2015 - 01/2008
3	osimertinibIBA 12/2021 - 10/2016
3	Pemetrexed (MTA)FDA Link 03/2021 - 03/2011
3	Everolimus FDA Link 01/2020 - 11/2009
3	AfatinibIBA 11/2018 - 09/2012
3	B7-H1 AntigenIBA 02/2018 - 02/2015
3	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2017 - 11/2012
3	RNA (Ribonucleic Acid)IBA 02/2015 - 05/2007
3	Dasatinib (BMS 354825)FDA Link 09/2011 - 06/2009
2	pembrolizumabIBA 12/2023 - 03/2021
2	EnzymesIBA 11/2023 - 06/2011
2	trametinibIBA 10/2023 - 12/2021
2	capmatinibIBA 01/2023 - 01/2020
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2022 - 01/2020
2	Alanine Transaminase (SGPT)IBA 10/2022 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 03/2021 - 11/2016
2	Programmed Cell Death 1 ReceptorIBA 01/2021 - 02/2015
2	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 09/2011
2	Tyrosine (L-Tyrosine)FDA Link 01/2019 - 06/2011
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019 - 09/2017
2	IntegrinsIBA 11/2018 - 01/2017
2	VemurafenibIBA 01/2018 - 08/2015
2	AntigensIBA 03/2017 - 02/2010
2	Immunoglobulin G (IgG)IBA 03/2017 - 03/2015
2	Etoposide (VP 16)FDA LinkGeneric 11/2016 - 01/2002
2	Monoclonal AntibodiesIBA 02/2015 - 02/2015
2	vandetanib (ZD6474)IBA 04/2013 - 03/2011
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2011 - 11/2009
2	Gefitinib (Iressa)FDA Link 06/2011 - 05/2011
2	Aripiprazole (Abilify)FDA Link 10/2007 - 09/2004
2	Transcription Factors (Transcription Factor)IBA 11/2005 - 07/2004
2	NF-kappa B (NF-kB)IBA 11/2005 - 07/2004
2	NF-KappaB Inhibitor alphaIBA 11/2005 - 07/2004
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2002 - 01/2002
1	repotrectinibIBA 01/2024
1	epidermal growth factor receptor VIIIIBA 11/2023
1	Protein Kinases (Protein Kinase)IBA 10/2023
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2023
1	naporafenibIBA 10/2023
1	Lipase (Acid Lipase)FDA Link 10/2023
1	Docetaxel (Taxotere)FDA Link 01/2023
1	amivantamab-vmjwIBA 01/2023

Therapy/Procedure

50	Therapeutics 04/2024 - 01/2002
8	Immunotherapy 03/2024 - 05/2007
7	Drug Therapy (Chemotherapy) 03/2024 - 12/2011
5	Genomic Medicine 01/2024 - 07/2015
4	Palliative Care (Palliative Therapy) 12/2023 - 05/2008
4	Radiotherapy 01/2021 - 01/2002
2	Aftercare (After-Treatment) 10/2016 - 01/2008
1	Precision Medicine 01/2024
1	Chemoradiotherapy 10/2023